The magic mushroom compound psilocybin shows long-lasting antidepressant effects in a clinical trial, with patients reporting ...

A single dose of synthetic psilocybin significantly reduced symptoms of treatment-resistant depression in a 6-week phase III ...

Compass Pathways said Monday it achieved its primary endpoint in an early readout from the largest-ever study of psilocybin ...

A new study shows promise for cancer patients. A single dose of psilocybin, found in certain mushrooms, can reduce depression ...

A single dose of psilocybin coupled with “talk therapy” can significantly reduce depression in people with cancer for up to ...

Findings showed COMP360 psilocybin statistically significantly reduced symptom severity compared with placebo, as measured by MADRS.

Compass Pathways' delayed phase 3 readout for its psilocybin treatment has hit its primary endpoint of reducing the severity ...

Psilocybin, the active ingredient in magic mushrooms, might just revolutionize how depression and anxiety are treated in ...

USA: A phase II trial published in the Cancer Journal has revealed that a single dose of psilocybin, when combined with ...

New research shows a single dose leads to 'robust' reductions in depression and anxiety up to 2 years afterward.

Legislation was introduced to decriminalize the use of psilocybin in Michigan as a post-traumatic stress disorder treatment.

Findings showed COMP360 psilocybin statistically significantly reduced symptom severity compared with placebo, as measured by MADRS (mean difference, -3.6 points [95% CI, -5.7, -1.5; P <.001).